Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Viewpoint - Hechuan Technology (688320.SH) announced a share reduction plan involving major shareholders and executives, indicating potential liquidity changes and market sentiment shifts [1][2][3] Share Reduction Plans - Major shareholder and vice general manager Xiang Henghui plans to reduce holdings by up to 2,728,922 shares, representing 1.8071% of total shares [1] - General manager Xu Xiaojie intends to reduce holdings by up to 1,146,496 shares, accounting for 0.7592% of total shares [1] - Vice general manager Yan Pengfei plans to reduce holdings by up to 655,141 shares, which is 0.4338% of total shares [1] - Related entities, including Qichuan Investment and Qichuan Hepeng, plan to collectively reduce up to 4,530,409 shares, representing 3.0000% of total shares [2] Financial Implications - The total estimated cash from the share reductions is approximately 334.17 million yuan based on the last closing price of 36.88 yuan per share [3] - As of the announcement date, major shareholders hold the following shares: Xiang Henghui (10,915,688 shares, 7.2283%), Xu Xiaojie (4,585,987 shares, 3.0368%), Yan Pengfei (2,620,564 shares, 1.7353%), and Qichuan Investment (13,919,927 shares, 9.2177%) [3] Company Background - Hechuan Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 28, 2022, with an initial offering price of 23.66 yuan per share [4] - The company raised a total of 893 million yuan, with a net amount of 807 million yuan after expenses [4] - In 2024, the company reported a revenue of 81.07 million yuan, a decrease of 27.39% year-on-year, and a net loss of 165.09 million yuan [5] - For the first nine months of 2025, the company achieved a revenue of 733 million yuan, a year-on-year increase of 13.83%, but still reported a net loss of 91.65 million yuan [5]

Core Viewpoint - Hechuan Technology (688320.SH) experienced a significant drop in stock price, reaching a new low since April 23, primarily due to planned share reductions by major shareholders and executives [1] Group 1: Shareholder Actions - Major shareholders, including the company's controlling shareholder and executives, plan to reduce their holdings through centralized bidding or block trading [1] - Xiang Henghui, the major shareholder, intends to reduce his stake by no more than 1.8071% of the total share capital [1] - General Manager Xu Xiaojie plans to reduce his stake by no more than 0.7592%, while Deputy General Manager Yan Pengfei aims to reduce his stake by no more than 0.4338% [1] Group 2: Additional Share Reductions - The actual controller's concerted action parties, including Qingchuan Investment, Quzhou Hepeng, and Quzhou Hejie, plan to collectively reduce their holdings by no more than 4,530,409 shares, which is up to 3% of the total share capital [1] - The reduction plan will be implemented within three months after the announcement, starting 15 trading days from the disclosure date [1]

Core Insights - On November 18, several companies disclosed their shareholding changes, with 康缘药业, 超达装备, and 海大集团 announcing share buybacks, while 15 companies, including 立达信 and 艾布鲁, reported share reductions [1][2]. Group 1: Share Buybacks - 康缘药业's actual controller and director, 肖伟, increased his shareholding by 20,000 shares [2]. - 超达装备 secured a stock repurchase loan commitment from China Bank for up to 450 million yuan [2]. - 海大集团 plans to repurchase shares worth no less than 1 billion yuan and up to 1.6 billion yuan [2]. Group 2: Share Reductions - 立达信's shareholder, 李春华, intends to reduce his stake by no more than 1.56% [2]. - 艾布鲁's controlling shareholder, 钟儒波, plans to reduce his stake by no more than 3% [2]. - 高德红外's actual controller, 黄立, aims to reduce his stake by no more than 3% [2]. - 嘉美包装's shareholders plan to collectively reduce their stake by no more than 1.16% [2]. - 蓄奥规划's shareholders intend to reduce their stake by no more than 1% [2]. - 君逸数码's shareholder, 成都高创投, plans to reduce his stake by no more than 1% [2]. - 联合水务's shareholder, 上海衡联, intends to reduce his stake by no more than 0.14% [2]. - 亚翔集成's second-largest shareholder has reduced 130,000 shares and is still in the reduction period [2]. - 芯朋微's controlling shareholder, 张立新, has terminated his reduction plan early [2]. - 安旭生物's shareholder, 马华祥, plans to reduce his stake by no more than 0.94% [2]. - 农心科技's shareholder, 宁波农旗, intends to reduce his stake by no more than 0.54% [2]. - 禾川科技's actual controller and others plan to reduce their stake by no more than 6% [2]. - 世龙实业's shareholder, 电化高科, plans to reduce his stake by no more than 3% [2]. - 中国化学's executive, 聂宁新, intends to reduce his stake by no more than 60,000 shares [2]. - 鸿泉技术's shareholder, 千方科技, plans to reduce his stake by no more than 3% [2].

禾川科技(688320.SH)发布公告，因自身资金需求，公司大股东、董事、副总经理项亨会先生，公司董 事、总经理徐晓杰先生，公司董事、副总经理鄢鹏飞先生拟通过集中竞价或大宗交易的方式减持其所持 有的公司股份合计不超3%。 因资金分配需求，公司实际控制人的一致行动人晴川投资、衢州禾鹏、衢州禾杰合计拟减持不超过 453.04万股，不超过公司总股本比例3%。 ...

因资金分配需求，公司实际控制人的一致行动人晴川投资、衢州禾鹏、衢州禾杰合计拟减持不超过 453.04万股，不超过公司总股本比例3%。 禾川科技(688320.SH)发布公告，因自身资金需求，公司大股东、董事、副总经理项亨会先生，公司董 事、总经理徐晓杰先生，公司董事、副总经理鄢鹏飞先生拟通过集中竞价或大宗交易的方式减持其所持 有的公司股份合计不超3%。 ...

人民财讯11月18日电，禾川科技(688320)11月18日公告，公司大股东、董事、副总经理项亨会，公司董 事、总经理徐晓杰，公司董事、副总经理鄢鹏飞拟通过集中竞价或大宗交易的方式合计减持不超过 3.0001%公司股份。公司实际控制人的一致行动人晴川投资、衢州禾鹏、衢州禾杰合计拟减持不超过 453.04万股，不超过公司总股本比例3.0000%。 ...

证券代码：688320 证券简称：禾川科技 公告编号：2025-063 浙江禾川科技股份有限公司 实际控制人的一致行动人、部分董事及高级管理人 员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 实际控制人的一致行动人、部分董事及高级管理人员持股的基本情况 截至本公告披露日，浙江禾川科技股份有限公司（以下简称"禾川科技"或"公 司"）本次拟减持的股东、董事及高级管理人员持股情况如下： 1、公司大股东、董事、副总经理项亨会先生持有公司股份数 10,915,688 股， 占公司总股本的 7.2283%； 2、公司董事、总经理徐晓杰先生持有公司股份数 4,585,987 股，占公司总股 本的 3.0368%； 3、公司董事、副总经理鄢鹏飞先生持有公司股份数 2,620,564 股，占公司总 股本的 1.7353%； 4、公司实际控制人的一致行动人衢州晴川创业投资合伙企业（有限合伙） （原名称为衢州禾川投资管理中心（有限合伙），2025 年 9 月名称发生变更，以 下简称"晴川投资"）持 ...

格隆汇11月18日丨禾川科技(688320.SH)公布，因自身资金需求，公司大股东、董事、副总经理项亨会 先生，公司董事、总经理徐晓杰先生，公司董事、副总经理鄢鹏飞先生拟通过集中竞价或大宗交易的方 式减持其所持有的公司股份。其中项亨会先生拟减持公司股份数量不超过2,728,922股，不超过公司总股 本比例的1.8071%，不超过其所持有的本公司股份总数的25%；徐晓杰先生拟减持公司股份数量不超过 1,146,496股，不超过公司总股本比例的0.7592%，不超过其所持有的本公司股份总数的25%；鄢鹏飞先 生拟减持公司股份数量不超过655,141股，不超过公司总股本比例的0.4338%，不超过其所持有的本公司 股份总数的25%。 因资金分配需求，公司实际控制人的一致行动人晴川投资、衢州禾鹏、衢州禾杰合计拟减持不超过 4,530,409股，不超过公司总股本比例3.0000%。其中，拟通过集中竞价方式合计减持不超过1,510,136 股，不超公司总股本比例1.0000%，拟通过大宗交易的方式合计减持不超过3,020,273股，不超公司总股 本比例2.0000%。公司控股股东、实际控制人、董事长王项彬先生不参与本次减 ...

禾川科技公告，项亨会持1091.57万股占7.2283%，拟2025年12月11日至2026年3月10日减不超272.89万 股占1.8071%；徐晓杰持458.6万股占3.0368%，拟减不超114.65万股占0.7592%；鄢鹏飞持262.06万股占 1.7353%，拟减不超65.51万股占0.4338%；晴川投资持1391.99万股占9.2177%，衢州禾杰持209.84万股占 1.3895%，衢州禾鹏持173.83万股占1.1511%，三者合计拟减不超453.04万股占3.0000%，竞价不超151.01 万股，大宗不超302.03万股。 ...